KEVIN RAY MCKENNEY
Pharmacy in Lansdale, PA
License number
Pennsylvania RP032419L
Category
Pharmacy
Type
Pharmacist
Address
Address
Lansdale, PA 19446
Professional information
Associate Director Process Validation At Mcneil Consumer Healthcare
Position:
Associate Director Process Validation at McNeil Consumer Healthcare, President at KR McKenney & Associates, LLC
Location:
Greater Philadelphia Area
Industry:
Pharmaceuticals
Work:
McNeil Consumer Healthcare
- Ft. Washington, PA since Jan 2012
-
Associate Director Process Validation
KR McKenney & Associates, LLC
- Lansdale, PA since Nov 2011
-
President
Merck&Co., Inc.
- West Point, PA Jan 2009 - Sep 2011
-
Project Scientist, Global Technical Operations
Merck&Co., Inc
- West Point, PA Jun 2007 - Dec 2008
-
Project Manager External Services
Merck
- West Point, PA Jun 2004 - May 2007
-
Manager – Early Phase Clinical Manufacturing
Merck
- West Point, PA Jan 2002 - May 2004
-
Manager – Pharmaceutical Process Technology
Merck
- West Point, PA Jan 1998 - Dec 2001
-
Manager – Pharmaceutical Manufacturing Technical Services
Merck
Nov 1995 - Dec 1997
-
Senior Project Scientist - Pharmaceutical Manufacturing Technical Services.
CIBA Sef Medication
Jan 1995 - Nov 1995
-
Senior Development Pharmacist - Consumer Product Research and Development
Education:
Villanova University 2011 - 2012
Six Sigma - Green Belt Certificate University of the Sciences in Philadelphia 1977 - 1982
BS, Pharmacy
Six Sigma - Green Belt Certificate University of the Sciences in Philadelphia 1977 - 1982
BS, Pharmacy
Interests:
Additional Professional Development: Registered Pharmacist, State of Pennsylvania; Project Management Principles & Practices; Systematic Project Management
Kevin Mckenney - Lansdale, PA
Work:
MERCK & CO., INC
Project Scientist - Global Technical Operations MERCK & CO., INC MERCK & CO., INC
Project Manager MERCK & CO., INC
Manager MERCK & CO., INC
Manager MERCK & CO., INC
Manager CIBA ELF-MEDICATION, INC - Fort Washington, PA
Senior Development Pharmacist - Consumer Product R&D
Project Scientist - Global Technical Operations MERCK & CO., INC MERCK & CO., INC
Project Manager MERCK & CO., INC
Manager MERCK & CO., INC
Manager MERCK & CO., INC
Manager CIBA ELF-MEDICATION, INC - Fort Washington, PA
Senior Development Pharmacist - Consumer Product R&D
Education:
Philadelphia College of Pharmacy & Science - Philadelphia, PA
BS in Pharmacy
BS in Pharmacy
Cb-1 Receptor Modulator Pharmaceutical Formulations
US Patent:
2010008, Apr 1, 2010
Filed:
Sep 14, 2009
Appl. No.:
12/558977
Inventors:
Eleni Dokou - Harleysville PA, US
Craig A. McKelvey - Ambler PA, US
Kevin R. McKenney - Lansdale PA, US
Andrey Peresypkin - Cambridge MA, US
Karen C. Thompson - Lansdale PA, US
W. Peter Wuelfing - Harleysville PA, US
Craig A. McKelvey - Ambler PA, US
Kevin R. McKenney - Lansdale PA, US
Andrey Peresypkin - Cambridge MA, US
Karen C. Thompson - Lansdale PA, US
W. Peter Wuelfing - Harleysville PA, US
International Classification:
A61K 31/4245, A61P 3/04, A61P 25/28
US Classification:
5142102
Abstract:
The present invention relates to pharmaceutical compositions that stabilize and improve the bioavailability of 3-[(1S)- 1-(1-{(S)-(4-chlorophenyl)[3-(5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)phenyl]methyl}azetidin-3-yl)-2-fluoro-2-methylpropyl]-5-fluorobenzonitrile. In particular, the present invention relates to pharmaceutical compositions that include 3-[(1S)-1-(1-{(S)-(4-chlorophenyl)[3 -(5-oxo-4,5-dihydro- 1,3,4-oxadiazol-2-yl)phenyl]methyl}azetidin-3-yl)-2-fluoro-2-methylpropyl]-5-fluorobenzonitrile and at least one pharmaceutical acceptable excipient, such as a mono-, di- or triglyceride.